Gritstone bio Inc (NASDAQ:GRTS)

1.95
Delayed Data
As of May 20
 0.00 / 0.00%
Today’s Change
1.82
Today|||52-Week Range
14.42
-84.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$139.4M

Company Description

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

Contact Information

Gritstone bio, Inc.
5959 Horton Street
Emeryville California 94608
P:(510) 871-6100
Investor Relations:

Employees

Shareholders

Other institutional31.55%
Individual stakeholders18.78%
Mutual fund holders11.43%

Top Executives

Andrew R. AllenPresident, Chief Executive Officer & Director
Erin E. JonesChief Operating Officer
Vassiliki Celia EconomidesChief Financial Officer & Executive Vice President
Karin JoossHead-Research & Development
Matthew HawrylukChief Business Officer & Executive Vice President